Bixiye
Commercial Pharmacy Program Policy Activity Provider Notification
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 561 - 570 ee natiijooyinka 3563
Bixiye
QP79-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP81-24 Health Equity Certification 2025 Launch
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP78-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP84-24 Commercial Pharmacy Benefit Exclusion for Tremfya® and Ocrevus Zunovo™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP83-24 MHCP Pharmacy Benefit Exclusion for Tremfya®, Tecentriq Hybreza™ and Ocrevus Zunovo™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP82-24 Enhanced Authorization Submissions through Availity Essentials
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP80-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024